All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available below. All relevant financial relationships have been mitigated in advance of this program.
Faculty Disclosures
Angelo Antonini
Speaker
Nothing to Disclose
Filip Bergquist
Speaker
Grant: Neuroförbundet, R&D Västra Götaland
K. Ray Chaudhuri
Speaker
Consultant: AbbVie, UCB, GKC, Bial, Cynapsus, Lobsor, Stada, Medtronic, Zambon, Profile, Sunovion, Roche, Theravance, Scion, Britannia, Acadia, 4D
Speaker: AbbVie, Britannia, UCB, Mundipharma, Zambon, Novartis,Boehringer Ingelheim
Grant: Britannia Pharmaceuticals, AbbVie, UCB, GKC, Bial, EU, IMI EU, Horizon 2020, Parkinson's UK, NIHR, PDNMG, EU (Horizon 2020), MRC, Wellcome Trust
David Devos
Planner, Speaker
Consultant: Abbvie, Alterity, Orkyn, Air Liquide, Apopharma, Lundbeck, Everpharma and Boston Scientific, Cure Parkinson Trust
Grant: PHRC grants, ANR, Coen, Horizon 2020
Equity Stake: InBrain Pharma
Cristian Falup-Pecurariu
Speaker
Nothing to Disclose
Tove Henriksen
Speaker
Researcher: AbbVie
Speaker: Britannia, EVER Pharma, AbbVie, Neuroderm
Per Odin
Planner, Speaker
Nothing to Disclose
Anna Sauerbier
Planner, Speaker
Nothing to Disclose
Fabrizio Stocchi
Speaker
Consultant: Chiesi Ltd., GlaxoSmithKline Plc., Impax Laboratories Inc., Lundbeck Ltd, Teva UK Limited, UCB Pharma Ltd, Merck & Co. Inc, Zambon Pharma, Novartis AG
Lars Timmermann
Speaker
Grant: Hoffnungsbaum e.V., Medtronic Inc., TEVA, Bayer, zur Rose Pharma, UCB
Speaker: TEVA, Lundbeck, Bracco, Gianni PR, Medas Pharma, UCB Schwarz Pharma, Desitin Pharma, Boehringer Ingelheim, GlaxoSmithKline, Eumecom, Orion Pharma, Medtronic, Boston Scientific, Cephalon, Abott, GE Medical
Consultant: Medtronic Inc., Boston Scientific, Bayer Healthcare, UCB Schwarz Pharma, AMN, GlaxoSmithKline, Abbott, Archimedes
Tamine Capato
Reviewer
Nothing to Disclose